FDA Acting Commissioner Kyle Diamantas Promises Pro-Life Agenda, Calls Advocates

May 14, 2026 - 04:00
FDA Acting Commissioner Kyle Diamantas Promises Pro-Life Agenda, Calls Advocates
From left to right, U.S. Secretary of Agriculture Brooke Rollins, International Dairy Foods Association CEO Michael Dykes, then-Food and Drug Administration (FDA) Deputy Commissioner for Human Foods Kyle Diamantas, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., and then-FDA Commissioner Martin Makary attend a news conference at the USDA headquarters building in Washington, D.C., on July 14, 2025. Diamantas became acting FDA commissioner after Makary’s resignation on May 12, 2026.

Diamantas was elevated after Commissioner Marty Makary resigned.